Aesthetic Medical International Holdings Group Limited (AIH) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Care Facilities secteur d'activité. Le siège social de l'entreprise est situé à Shenzhen, China. Le PDG actuel est Pengwu Zhou.
AIH a date d'introduction en bourse 2019-10-25, 1,286 employés à temps plein, cotée sur le NASDAQ Global Market, une capitalisation boursière de $15.93M.
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. It offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments comprising minimally invasive and energy-based treatments, including laser, ultrasound, and ultraviolet light treatments. The company also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. It operates 15 treatment centers in China, Hong Kong, and Singapore. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
